Graybug Vision appoints Dirk Sauer to board; Gerald Cagle resigns as director
CalciMedica, Inc.
Gerald Cagle resigned as director and from Nominating and Governance Committee effective April 13, 2022; will remain as paid advisor.
Dirk Sauer appointed to board to fill vacancy, will serve as Class I director, expected to stand for election at 2024 annual meeting.
Sauer will chair newly formed Science and Innovation Committee; compensation includes $40k annual retainer, $4k committee fee, and 80,000 share option grant vesting over 3 years.
Sauer brings 30+ years ophthalmic drug development experience, previously led Novartis Ophthalmology Development Unit.
On April 13, 2022, the Board of Directors (the “Board”) of Graybug Vision, Inc. (the “Company”) received a letter from Gerald D. Cagle, Ph.D resigning as a director of the Company and as a member of the Nominating and Corporate Governance Committee of the Board, effective as of that day.
On April 13, 2022 (the “Effective Date”) , the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dirk Sauer, Ph.D, age 62, to serve as a member of the Board to fill the vacancy that was created by the resignation of Dr. Cagle described above.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Gerald D. Cagle resigned as Director at CalciMedica, Inc..
Action
resigned
Role
Director
Exact text from the filing
On April 13, 2022, the Board of Directors (the “Board”) of Graybug Vision, Inc. (the “Company”) received a letter from Gerald D. Cagle, Ph.D resigning as a director of the Company and as a member of the Nominating and Corporate Governance Committee of the Board, effective as of that day.
Dirk Sauer was appointed as Director at CalciMedica, Inc..
Action
appointed
Role
Director
Exact text from the filing
On April 13, 2022 (the “Effective Date”) , the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dirk Sauer, Ph.D, age 62, to serve as a member of the Board to fill the vacancy that was created by the resignation of Dr. Cagle described above.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.